Zhejiang Wecome Pharmaceutical Company Limited reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 501.41 million compared to CNY 472.39 million a year ago. Revenue was CNY 501.41 million compared to CNY 472.39 million a year ago.

Net income was CNY 92.72 million compared to CNY 89.3 million a year ago. Basic earnings per share from continuing operations was CNY 0.6404 compared to CNY 0.6167 a year ago. Diluted earnings per share from continuing operations was CNY 0.6404 compared to CNY 0.6167 a year ago.